Lynne Chou O'Keefe - Mar 15, 2022 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Director
Signature
/s/ Soleil Boughton, Attorney-in-Fact
Stock symbol
HIMS
Transactions as of
Mar 15, 2022
Transactions value $
$0
Form type
4
Date filed
3/17/2022, 07:11 PM
Previous filing
Mar 3, 2022
Next filing
Mar 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Options Exercise +10K 10K Mar 15, 2022 Direct F1
holding HIMS Class A Common Stock 158K Mar 15, 2022 Held by Define Ventures Fund I, L.P. F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Restricted Stock Unit Options Exercise $0 -17 -7.98% $0.00 196 Mar 15, 2022 Class A Common Stock 17 Direct F1, F3
transaction HIMS Restricted Stock Unit Options Exercise $0 -894 -8.34% $0.00 9.83K Mar 15, 2022 Class A Common Stock 894 Direct F1, F3
transaction HIMS Restricted Stock Unit Options Exercise $0 -9.13K -8.33% $0.00 100K Mar 15, 2022 Class A Common Stock 9.13K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU.
F2 Ms.Chou O'Keefe may be deemed a beneficial owner of the securities held by Define Ventures Fund I, L.P..
F3 The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company.